EP0956032A4 - Proteins and compositions for modulating mitosis - Google Patents

Proteins and compositions for modulating mitosis

Info

Publication number
EP0956032A4
EP0956032A4 EP97950984A EP97950984A EP0956032A4 EP 0956032 A4 EP0956032 A4 EP 0956032A4 EP 97950984 A EP97950984 A EP 97950984A EP 97950984 A EP97950984 A EP 97950984A EP 0956032 A4 EP0956032 A4 EP 0956032A4
Authority
EP
European Patent Office
Prior art keywords
proteins
compositions
mitosis
modulating
modulating mitosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97950984A
Other languages
German (de)
French (fr)
Other versions
EP0956032A1 (en
Inventor
Wen-Hwa Lee
Yumay Chen
Daniel J Riley
Phang-Lang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of EP0956032A1 publication Critical patent/EP0956032A1/en
Publication of EP0956032A4 publication Critical patent/EP0956032A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP97950984A 1996-12-20 1997-12-17 Proteins and compositions for modulating mitosis Withdrawn EP0956032A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3360096P 1996-12-20 1996-12-20
US33600P 1996-12-20
PCT/US1997/023385 WO1998027994A1 (en) 1996-12-20 1997-12-17 Proteins and compositions for modulating mitosis

Publications (2)

Publication Number Publication Date
EP0956032A1 EP0956032A1 (en) 1999-11-17
EP0956032A4 true EP0956032A4 (en) 2002-09-04

Family

ID=21871338

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97950984A Withdrawn EP0956032A4 (en) 1996-12-20 1997-12-17 Proteins and compositions for modulating mitosis

Country Status (5)

Country Link
EP (1) EP0956032A4 (en)
JP (1) JP2001507226A (en)
AU (1) AU5384898A (en)
CA (1) CA2274734A1 (en)
WO (1) WO1998027994A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (en) 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin regulatory genes
US6476193B1 (en) * 1998-10-06 2002-11-05 Curagen Corporation NLK1 protein and NLK1 protein complexes
EP1129351A2 (en) 1998-11-13 2001-09-05 Curagen Corporation COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-$g(a) MEDIATED PATHWAY
EP1029547A1 (en) 1999-02-15 2000-08-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Pharmaceutically active compounds and method for identifying same
US20020039776A1 (en) 2000-06-09 2002-04-04 Thomas Jenuwein Mammalian SUV39H2 proteins and isolated DNA molecules encoding them

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (en) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018126A1 (en) * 1997-10-07 1999-04-15 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH
EP1022286A1 (en) * 1997-10-07 2000-07-26 Ono Pharmaceutical Co., Ltd. POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
COMPTON D A ET AL: "PRIMARY STRUCTURE OF NUMA, AN INTRANUCLEAR PROTEIN THAT DEFINES A NOVEL PATHWAY FOR SEGREGATION OF PROTEINS AT MITOSIS", JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, US, vol. 116, no. 6, 1 March 1992 (1992-03-01), pages 1395 - 1408, XP000601680, ISSN: 0021-9525 *
DATABASE GENBANK [online] 20 March 1995 (1995-03-20), HILLIER ET AL.: "The WashU-Merck EST project", XP002203305, Database accession no. T89463 *
DATABASE GENBANK [online] 25 August 1995 (1995-08-25), HILLIER ET AL.: "The WashU-Merck EST project", XP002203306, Database accession no. R92253 *
DURFEE T ET AL: "THE RETINOBLASTOMA PROTEIN ASSOCIATES WITH THE PROTEIN PHOSPHATASE TYPE 1 CATALYTIC SUBUNIT", GENES AND DEVELOPMENT, COLD SPRING HARBOR, NY, US, vol. 7, no. 4, 1 April 1993 (1993-04-01), pages 555 - 567, XP000571493, ISSN: 0890-9369 *
See also references of WO9827994A1 *

Also Published As

Publication number Publication date
EP0956032A1 (en) 1999-11-17
JP2001507226A (en) 2001-06-05
WO1998027994A1 (en) 1998-07-02
AU5384898A (en) 1998-07-17
CA2274734A1 (en) 1998-07-02

Similar Documents

Publication Publication Date Title
IL130396A0 (en) OB fusion protein compositions and methods
IL129138A0 (en) Methods and compositions for immunomodulation
HU9602311D0 (en) Binding protein function modulator
AU2514592A (en) Methods and compositions for modulating g protein action
EP0897264A4 (en) Natural antioxidant composition
ZA9710419B (en) Compositions and methods for regulating apoptosis
AU1731997A (en) Antipathogenic peptides and compositions comprising them
AU3379497A (en) Stabilized hinokitiol and compositions containing same
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
EP0904539A4 (en) Inhibiting protein interactions
ZA9710338B (en) Proteins
GB9614033D0 (en) Modified protein G and fragments thereof
EP0956032A4 (en) Proteins and compositions for modulating mitosis
AU6795898A (en) Proteins and compositions for modulating mitosis
IL125933A0 (en) Canine ob protein compositions and methods
ZA976294B (en) Collagen blend
GB2308849B (en) Gasoline compositions
IL140574A0 (en) Methods and compositions for modulating spermatogenesis
AUPO982097A0 (en) Methods and compositions for use therein
IL116976A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
ZA971900B (en) Modified proteins
GB9828346D0 (en) Protein and compositions containing it
AU904P (en) Cawana Glycine max
GB9721869D0 (en) Protein and compositions containing it
GB9726586D0 (en) Protein and compositions containing it

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990716

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020718

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020701